100 related articles for article (PubMed ID: 23900351)
21. Diminished expression of MiR-15a is an independent prognostic marker for breast cancer cases.
Shinden Y; Akiyoshi S; Ueo H; Nambara S; Saito T; Komatsu H; Ueda M; Hirata H; Sakimura S; Uchi R; Takano Y; Iguchi T; Eguchi H; Sugimachi K; Kijima Y; Ueo H; Natsugoe S; Mimori K
Anticancer Res; 2015 Jan; 35(1):123-7. PubMed ID: 25550542
[TBL] [Abstract][Full Text] [Related]
22. From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).
Piva R; Spandidos DA; Gambari R
Int J Oncol; 2013 Oct; 43(4):985-94. PubMed ID: 23939688
[TBL] [Abstract][Full Text] [Related]
23. The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints.
Mei Z; Su T; Ye J; Yang C; Zhang S; Xie C
Radiat Res; 2015 Feb; 183(2):196-207. PubMed ID: 25594541
[TBL] [Abstract][Full Text] [Related]
24. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
Lin K; Farahani M; Yang Y; Johnson GG; Oates M; Atherton M; Douglas A; Kalakonda N; Pettitt AR
Br J Haematol; 2014 Nov; 167(3):346-55. PubMed ID: 25040181
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
Luo Q; Wei C; Li X; Li J; Chen L; Huang Y; Song H; Li D; Fang L
Oncol Rep; 2014 Mar; 31(3):1096-102. PubMed ID: 24402230
[TBL] [Abstract][Full Text] [Related]
26. Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer.
Abbas Syed R; Davey MG; Richard V; Miller N; Kerin MJ
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628874
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition.
Hu Q; Huang T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240281
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy.
Fukazawa T; Tanimoto K; Yamaoka E; Kojima M; Kanawa M; Hirohashi N; Hiyama E
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230656
[TBL] [Abstract][Full Text] [Related]
29. Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer.
Powrózek T; Ochieng Otieno M
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159070
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatic analysis of the expression and prognosis of ZNF589 in human breast cancer.
Fan J; Zhang Z; Chen D; Chen H; Yuan W; Zhou L; Xu J; Liu W; Xu Y
Transl Cancer Res; 2021 May; 10(5):2286-2304. PubMed ID: 35116546
[TBL] [Abstract][Full Text] [Related]
31. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization.
You Z; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X
J Cell Mol Med; 2021 Oct; 25(19):9168-9182. PubMed ID: 34510715
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
Yuan Q; Zheng L; Liao Y; Wu G
World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
34. The Physiological MicroRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum.
Patuleia SIS; van Gils CH; Oneto Cao AM; Bakker MF; van Diest PJ; van der Wall E; Moelans CB
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187146
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑15a‑5p‑targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.
Chen X; Cao R; Liu H; Zhang T; Yuan X; Xu S
Int J Mol Med; 2020 Oct; 46(4):1301-1310. PubMed ID: 32945353
[TBL] [Abstract][Full Text] [Related]
36. MiR-15a attenuates peripheral nerve injury-induced neuropathic pain by targeting AKT3 to regulate autophagy.
Cai L; Liu X; Guo Q; Huang Q; Zhang Q; Cao Z
Genes Genomics; 2020 Jan; 42(1):77-85. PubMed ID: 31736006
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray.
Alshabi AM; ; Shaikh IA; Vastrad C
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31311202
[No Abstract] [Full Text] [Related]
38. Prognostic Value of MicroRNA-15a in Human Cancers: A Meta-Analysis and Bioinformatics.
Yang FR; Li HJ; Li TT; Zhao YF; Liu ZK; Li XR
Biomed Res Int; 2019; 2019():2063823. PubMed ID: 31061821
[TBL] [Abstract][Full Text] [Related]
39. Expression signatures and roles of microRNAs in inflammatory breast cancer.
Qi Y; Wang X; Kong X; Zhai J; Fang Y; Guan X; Wang J
Cancer Cell Int; 2019; 19():23. PubMed ID: 30733644
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma.
Li H; Zhao X; Li C; Sheng C; Bai Z
Cancer Manag Res; 2019; 11():877-897. PubMed ID: 30697079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
